Clinical Trial Registries and Result Disclosure

Step-by-Step Guide to Registering a Trial on ClinicalTrials.gov

Posted on digi By digi

ClinicalTrials.gov is a publicly accessible database managed by the U.S. National Library of Medicine and mandated by FDAAA 801, 42 CFR Part 11, and the ICMJE. Sponsors, investigators, and responsible parties are required to register trials to promote transparency, enable ethical oversight, and meet legal disclosure requirements. Failure to register or disclose results can lead to noncompliance notices, financial penalties, and publication restrictions.
Click to read the full article.

Clinical Trial Registries and Result Disclosure, ClinicalTrials.gov Registration

Essential Data Fields Required for ClinicalTrials.gov Registration

Posted on digi By digi

Registering a clinical trial on ClinicalTrials.gov is a regulatory requirement under FDAAA 801 and 42 CFR Part 11 for most interventional studies conducted in the U.S. or funded by the NIH. Accurate and complete entry of data fields ensures transparency, supports ethical review, and fulfills obligations toward journal publication per ICMJE mandates. This tutorial outlines all essential fields you must populate in the Protocol Registration and Results System (PRS) to successfully register your trial and pass QC review.
Click to read the full article.

Clinical Trial Registries and Result Disclosure, ClinicalTrials.gov Registration

Avoiding Common Errors in ClinicalTrials.gov Entries

Posted on digi By digi

Registering a clinical trial on ClinicalTrials.gov is more than a formality—it’s a legal, ethical, and scientific responsibility. Inaccurate or incomplete entries can delay your study’s visibility, lead to regulatory penalties, and even jeopardize journal publication. This tutorial breaks down the most common errors flagged by the Protocol Registration and Results System (PRS) Quality Control (QC) reviewers and offers practical tips to ensure your submission is compliant and promptly approved.
Click to read the full article.

Clinical Trial Registries and Result Disclosure, ClinicalTrials.gov Registration

Timing of Registration for IND and Non-IND Trials

Posted on digi By digi

Accurate and timely registration of clinical trials is mandated by global regulatory authorities to ensure transparency, accountability, and ethical conduct. In the U.S., ClinicalTrials.gov registration is governed by laws like FDAAA 801 and regulations under 42 CFR Part 11. The timeline for registering a trial varies depending on whether it falls under an Investigational New Drug (IND) application or is a non-IND study. Understanding these distinctions and the required deadlines is vital for sponsors and research teams to avoid penalties, public notices of noncompliance, or delays in publication eligibility.
Click to read the full article.

Clinical Trial Registries and Result Disclosure, ClinicalTrials.gov Registration

Correcting and Updating Registered Trial Data on ClinicalTrials.gov

Posted on digi By digi

ClinicalTrials.gov serves as the public-facing record of clinical studies and their outcomes. Maintaining an accurate, up-to-date registry is not just good practice—it is a regulatory requirement under FDAAA 801, 42 CFR Part 11, and ICMJE policies. Sponsors and investigators must ensure that their study records reflect protocol changes, recruitment status, and result postings accurately. Failure to update trial data may lead to compliance issues, public mistrust, and publication rejections. This article walks you through the processes, responsibilities, timelines, and best practices for correcting and updating trial records.
Click to read the full article.

Clinical Trial Registries and Result Disclosure, ClinicalTrials.gov Registration

FDA Compliance Monitoring for ClinicalTrials.gov Registration and Results

Posted on digi By digi

The U.S. Food and Drug Administration (FDA) actively oversees compliance with clinical trial registration and result disclosure obligations under the FDA Amendments Act of 2007 (FDAAA 801) and 42 CFR Part 11. These regulations require sponsors and certain investigators to register applicable clinical trials (ACTs) on ClinicalTrials.gov and submit summary results within specific timelines. The FDA has the authority to enforce these mandates through inspections, warning letters, and civil monetary penalties. Non-compliance can lead to reputational damage, legal repercussions, and impact on product approvals.
Click to read the full article.

Clinical Trial Registries and Result Disclosure, ClinicalTrials.gov Registration

Consequences of Late or Missing Trial Registration

Posted on digi By digi

Clinical trial registration is no longer optional—it’s a regulatory requirement under U.S. FDAAA 801, a global transparency expectation, and an ethical necessity. Sponsors, CROs, and investigators are required to register applicable clinical trials (ACTs) on ClinicalTrials.gov before the enrollment of the first subject. Delays or omissions can lead to serious consequences including monetary penalties, reputational loss, publication barriers, and inspection findings. This tutorial unpacks the legal mandates, journal policies, and real-world risks associated with late or missing trial registration.
Click to read the full article.

Clinical Trial Registries and Result Disclosure, ClinicalTrials.gov Registration

Case Studies of High-Profile Registration Failures

Posted on digi By digi

Clinical trial registries such as ClinicalTrials.gov are foundational for transparency and public trust in pharmaceutical research. However, even top-tier pharma companies and academic institutions have failed to meet their legal obligations under FDAAA 801 and other global guidelines. These failures lead to reputational damage, regulatory sanctions, and scientific setbacks. In this article, we will explore real-world examples of high-profile trial registration failures, dissect what went wrong, and outline the lessons clinical teams must learn to avoid repeating history.
Click to read the full article.

Clinical Trial Registries and Result Disclosure, ClinicalTrials.gov Registration